Sitazan (50/500mg) 14 Tablets
Sitagliptin and metformin 50/500mg for type 2 diabetes.
Sitazan (50/500mg) combines sitagliptin (DPP-4 inhibitor) and metformin for type 2 diabetes. Used when dual therapy is needed for glycaemic control. Take once or twice daily with meals as directed; swallow whole.
Purpose
Treatment of type 2 diabetes mellitus as adjunct to diet and exercise when dual therapy is appropriate.
Ingredients
Sitagliptin 50mg and metformin hydrochloride 500mg per tablet.
Warnings
Contraindicated in severe renal impairment and diabetic ketoacidosis. Not for type 1 diabetes. Risk of lactic acidosis with metformin.
Side Effects
Nausea, diarrhoea, abdominal discomfort, hypoglycaemia when combined with insulin or sulphonylurea. Rare: pancreatitis. Report severe abdominal pain.
Storage Instructions
Store below 30°C in a dry place. Keep in original pack; protect from moisture.
| Brand | Cell |
| Status | Active |
Related Products
